Table A.11.
Summary statistics of total chronic dietary exposure to fludioxonil across European dietary surveys (premarketing scenario)
| Level of exposurea | Age class | N | Total chronic dietary exposure (% ADI) | ||
|---|---|---|---|---|---|
| Minimum | Median | Maximum | |||
| Mean | Infants (3–6 months) | 3 | 2.4 | 3.9 | 5.3 |
| Infants (6–12 months) | 6 | 5.3 | 6.8 | 11.0 | |
| Toddlers | 10 | 8.3 | 15.8 | 38.0 | |
| 95th percentile | Infants (3–6 months) | 2 | 10.2 | 14.1 | 17.9 |
| Infants (6–12 months) | 5 | 13.5 | 17.6 | 27.6 | |
| Toddlers | 7 | 19.2 | 39.6 | 49.9 | |
| 97.5th percentile | Infants (3–6 months) | 1 | 19.9 | 19.9 | 19.9 |
| Infants (6–12 months) | 4 | 15.8 | 19.0 | 35.5 | |
| Toddlers | 7 | 27.6 | 50.0 | 62.6 | |
N: number of surveys.
a
The 95th and 97.5th percentile estimates obtained on dietary surveys/age classes with less than 61 and 181 observations, respectively, may not be statistically robust (EFSA, 2011a). Those estimates were not included in this table.